{"id":10567,"date":"2023-02-03T15:06:22","date_gmt":"2023-02-03T14:06:22","guid":{"rendered":"http:\/\/bigman.to\/?post_type=product&#038;p=10567"},"modified":"2026-08-13T22:03:00","modified_gmt":"2026-08-13T20:03:00","slug":"pharma-lab-nandrolone-phenylpropionate-10-amps-10x-100-mg-ml","status":"publish","type":"product","link":"https:\/\/bigman.to\/lt\/produktas\/pharma-lab-nandrolone-phenylpropionate-10-amps-10x-100-mg-ml\/","title":{"rendered":"Pharma Lab Nandrolone Phenylpropionate 10 amps (10x 100 mg\/ml)"},"content":{"rendered":"<h2>Nandrolono fenilpropionatas<\/h2><p>Nandrolono fenilpropionatas yra injekcinis anabolinis steroidas, strukt\u016bri\u0161kai pana\u0161us \u012f deka-durabolin\u0105, kuris naudoja l\u0117tesn\u012f nandrolono dekanoato atpalaidavim\u0105. Esminis skirtumas - i\u0161siskyrimo greitis; nandrolono dekanoatas i\u0161laiko padid\u0117jus\u012f kiek\u012f ma\u017edaug tris savaites, o nandrolono fenilpropionatas veiksmingas tik vien\u0105 savait\u0119. Klinikiniu atveju deka-durabolin\u0105 galima vartoti kart\u0105 per 2-3 savaites, o durabolino paprastai reikia injection kas kelias dienas ar kart\u0105 per savait\u0119. Ta\u010diau \u0161ie du steroidai turi pana\u0161i\u0105 naud\u0105, nes abu yra \u0161ven\u010diami tarp sportinink\u0173 ir kult\u016brist\u0173 d\u0117l j\u0117gos ir liesos raumen\u0173 mas\u0117s didinimo, kartu suma\u017einant estrogenin\u012f ar androgenin\u012f \u0161alutin\u012f poveik\u012f.<\/p><h3>Strukt\u016brin\u0117s charakteristikos<\/h3><p>Nandrolono fenilpropionatas yra modifikuota nandrolono forma, prie 17-beta hidroksilo grup\u0117s prijungiant propiono fenilo ester\u012f. Esterifikuoti steroidai l\u0117\u010diau absorbuojami, o pa\u0161alinus ester\u012f kraujyje susidaro laisvas nandrolonas. Tai leid\u017eia pasiekti ilgesn\u012f gydom\u0105j\u012f poveik\u012f ir re\u010diau vartoti dozes nei neesterifikuotus steroidus. Po giliai \u012f raumenis \u012fvesto injection nandrolono fenilpropionato per 24-48 valandas greitai i\u0161siskiria nandrolono kiekis, kuris per savait\u0119 suma\u017e\u0117ja iki pradinio lygio.<\/p><h3>\u0160alutinis poveikis (estrogeninis)<\/h3><p>\u017dinomas ma\u017eas polinkis \u012f estrogen\u0173 konversij\u0105 - apie 20% testosterono - nandrolonas suma\u017eina susir\u016bpinim\u0105 d\u0117l estrogeninio \u0161alutinio poveikio. Nors kepenyse nandrolonas gali virsti estradioliu, jo geb\u0117jimas daug ma\u017eesnis aktyviose steroid\u0173 aromatizacijos vietose, pavyzd\u017eiui, riebaliniame audinyje. Ta\u010diau padid\u0117j\u0119s estrogen\u0173 kiekis, vartojant dideles dozes, vis tiek gali sukelti \u0161alutin\u012f poveik\u012f, pavyzd\u017eiui, vandens susilaikym\u0105, padid\u0117jus\u012f k\u016bno riebal\u0173 kiek\u012f ir ginekomastij\u0105. Jei atsiranda toks \u0161alutinis poveikis, gali b\u016bti b\u016btini antiestrogenai, pavyzd\u017eiui, klomifeno citratas arba tamoksifeno citratas. Arba aromataz\u0117s inhibitoriai, tokie kaip arimideksas, gali veiksmingai reguliuoti estrogen\u0173 kiek\u012f, ta\u010diau jie gali b\u016bti brangesni ir tur\u0117ti neigiam\u0105 poveik\u012f kraujo lipidams.<\/p><p>Nandrolonas taip pat pasi\u017eymi \u012f progestin\u0105 pana\u0161iu poveikiu. D\u0117l 19-norprogesterono strukt\u016bros padid\u0117ja jo giminingumas progesterono receptoriui, tod\u0117l atsiranda sinergija su estrogenu, galinti sustiprinti ginekomastij\u0105. Vartojant antiestrogen\u0173 galima suma\u017einti \u0161\u012f poveik\u012f.<\/p><h3>\u0160alutinis poveikis (androgeninis)<\/h3><p>Nors nandrolonas pirmiausia yra anabolinis, gali pasireik\u0161ti galimas androgeninis \u0161alutinis poveikis, ypa\u010d vartojant didesnes dozes, \u012fskaitant riebi\u0105 od\u0105, spuogus ir padid\u0117jus\u012f plauk\u0173 augim\u0105. Be to, vartotojams gali pa\u016bm\u0117ti vyri\u0161kas plauk\u0173 slinkimas, o moterys gali susidurti su virilizacijos simptomais, tokiais kaip balso pagil\u0117jimas ir klitorio padid\u0117jimas. D\u0117l ma\u017eesnio androgeninio aktyvumo, palyginti su tokiais steroidais kaip testosteronas, stiprus androgeninis \u0161alutinis poveikis yra ma\u017eiau tik\u0117tinas. Ta\u010diau reikia b\u016bti atsargiems, nes nandrolonas gali slopinti lytin\u012f potrauk\u012f, jei jis nesuderintas su kitu androgenu.<\/p><p>\u012e androgenus reaguojan\u010diose srityse, pavyzd\u017eiui, galvos odoje ir prostatoje, nandrolono poveikis su\u0161velninamas fermentui 5-alfa reduktaz\u0117 paver\u010diant j\u012f dihidronandrolonu (DHN). Vartojant 5-alfa reduktaz\u0117s inhibitorius, pavyzd\u017eiui, finasterid\u0105, gali sustipr\u0117ti nandrolono androgeninis \u0161alutinis poveikis, tod\u0117l, norint i\u0161laikyti ma\u017eesn\u012f androgeni\u0161kum\u0105, jo reik\u0117t\u0173 vengti.<\/p><h3>\u0160alutinis poveikis (hepatotoksi\u0161kumas)<\/h3><p>Nandrolonas n\u0117ra C-17 alfa alkilintas, o tai rodo ma\u017e\u0105 hepatotoksi\u0161kumo rizik\u0105 sveikiems \u017emon\u0117ms.<\/p><h3>\u0160alutinis poveikis (\u0161irdies ir kraujagysli\u0173 sistemos)<\/h3><p>Anaboliniai (androgeniniai) steroidai, tokie kaip nandrolonas, gali neigiamai paveikti cholesterolio kiek\u012f serume, suma\u017einti DTL (gerojo cholesterolio) kiek\u012f ir padidinti MTL (blogojo cholesterolio) kiek\u012f, o tai gali padidinti ateroskleroz\u0117s rizik\u0105. \u012etaka serumo lipidams priklauso nuo doz\u0117s, vartojimo b\u016bdo (geriamojo ar injekciniotable), steroid\u0173 tipo ir kepen\u0173 atsparumo metabolizmui. Tyrimai rodo, kad nandrolono dekanoato, rodan\u010dio stipresn\u012f neigiam\u0105 poveik\u012f, palyginti su testosterono cipionatu, labai suma\u017e\u0117ja DTL kiekis. \u0160irdies ir kraujagysli\u0173 sistemos rizika gali dar labiau padid\u0117ti d\u0117l galimo poveikio kraujosp\u016bd\u017eiui, trigliceridams ir \u0161irdies raumens hipertrofijai.<\/p><h3>\u0160alutinis poveikis (testosterono slopinimas)<\/h3><p>Nandrolonas, kaip ir visi anaboliniai\/androgeniniai steroidai, vartojami raumenis formuojan\u010diomis doz\u0117mis, gali slopinti nat\u016brali\u0105 testosterono gamyb\u0105. Tyrimai rodo, kad netable suma\u017e\u0117ja - ma\u017edaug 57%, kai vartojama 100mg per savait\u0119, o kai vartojama 300mg - iki 70%. Progestacinis nandrolono pob\u016bdis sustiprina testosterono slopinim\u0105, kuris paprastai normalizuojasi per 2-6 m\u0117nesius po vartojimo nutraukimo. Vartotojai tur\u0117t\u0173 i\u0161likti atsarg\u016bs d\u0117l hipogonadotrofinio hipogonadizmo galimyb\u0117s, atsirandan\u010dios d\u0117l netinkamo steroid\u0173 vartojimo.<\/p><h3>Administracija (vyrai)<\/h3><p>Rekomenduojamos doz\u0117s bendram anaboliniam poveikiui pasiekti svyruoja nuo 25 iki 50mg per savait\u0119 per 12 savai\u010di\u0173. Norint pagerinti k\u016bno sud\u0117jim\u0105, paprastai vartojamos nuo 200 iki 400mg savaitin\u0117s doz\u0117s, kurios skiriamos 8-12 savai\u010di\u0173 trukm\u0117s ciklams. D\u0117l greito fenilpropionato esterio veikimo paprastai \u0161ios doz\u0117s dalijamos \u012f du kartus per savait\u0119.<\/p><h3>Administracija (moterys)<\/h3><p>Pana\u0161iose rekomendacijose moterims rekomenduojama vartoti nuo 25 iki 50mg per savait\u0119 12 savai\u010di\u0173, kad b\u016bt\u0173 u\u017etikrintas bendras veiksmingumas. Fizinio paj\u0117gumo gerinimo atvejais \u012fprasta vartoti 50mg per savait\u0119 (per vien\u0105 injection) 4-6 savai\u010di\u0173 cikluose. Didesn\u0117s doz\u0117s sukelia androgenin\u012f \u0161alutin\u012f poveik\u012f, tod\u0117l reikia nedelsiant nutraukti gydym\u0105, kad b\u016bt\u0173 su\u0161velninti virilizacijos simptomai.<\/p>","protected":false},"excerpt":{"rendered":"<p><strong>Pharma Lab Nandrolone Phenylpropionate 10 amps (10x 100 mg\/ml)<\/strong> is a powerful injectable anabolic steroid that promotes rapid muscle growth and strength gains. With its swift release into the bloodstream, this effective formulation minimizes estrogenic and androgenic side effects, making it a favorite among athletes and bodybuilders looking to enhance their performance safely.<\/p>","protected":false},"featured_media":827114,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[461],"product_tag":[490,491,486,499,504,488,489],"class_list":{"0":"post-10567","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-nandrolone-phenylpropionate","7":"product_tag-for-men","8":"product_tag-for-women","9":"product_tag-injectable","10":"product_tag-keep-gains","11":"product_tag-nandrolone-phenylpropionate","12":"product_tag-strenght","13":"product_tag-weight-gain","14":"pa_brand-pharma-lab","16":"first","17":"outofstock","18":"sale","19":"shipping-taxable","20":"purchasable","21":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/bigman.to\/lt\/wp-json\/wp\/v2\/product\/10567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bigman.to\/lt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/bigman.to\/lt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/bigman.to\/lt\/wp-json\/wp\/v2\/comments?post=10567"}],"version-history":[{"count":12,"href":"https:\/\/bigman.to\/lt\/wp-json\/wp\/v2\/product\/10567\/revisions"}],"predecessor-version":[{"id":834795,"href":"https:\/\/bigman.to\/lt\/wp-json\/wp\/v2\/product\/10567\/revisions\/834795"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bigman.to\/lt\/wp-json\/wp\/v2\/media\/827114"}],"wp:attachment":[{"href":"https:\/\/bigman.to\/lt\/wp-json\/wp\/v2\/media?parent=10567"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/bigman.to\/lt\/wp-json\/wp\/v2\/product_brand?post=10567"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/bigman.to\/lt\/wp-json\/wp\/v2\/product_cat?post=10567"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/bigman.to\/lt\/wp-json\/wp\/v2\/product_tag?post=10567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}